Cultures derived from pancreatic cancer xenografts with long-term gemcitabine treatment produce chemoresistant secondary xenografts: Establishment of isogenic gemcitabine-sensitive and -resistant models

Update your browser to view ScienceDirect.

Request details:

Request ID: 8d44ef136dbbcf2d-LAX
IP: 101.37.83.79
UTC time: 2024-10-18T02:00:17+00:00
Browser: Mozilla/5.0 (X11; U; Linux x86_64; en-US; rv:1.9.1.4) Gecko/20091030 Gentoo Firefox/3.5.4